188 related articles for article (PubMed ID: 8523123)
1. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.
Ding YS; Fowler JS; Volkow ND; Logan J; Gatley SJ; Sugano Y
J Nucl Med; 1995 Dec; 36(12):2298-305. PubMed ID: 8523123
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron.
Ding YS; Fowler JS; Volkow ND; Gatley SJ; Logan J; Dewey SL; Alexoff D; Fazzini E; Wolf AP
Synapse; 1994 Oct; 18(2):152-60. PubMed ID: 7839313
[TBL] [Abstract][Full Text] [Related]
3. A new PET ligand for the dopamine transporter: studies in the human brain.
Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N
J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098
[TBL] [Abstract][Full Text] [Related]
4. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain.
Ding YS; Fowler JS; Volkow ND; Dewey SL; Wang GJ; Logan J; Gatley SJ; Pappas N
Psychopharmacology (Berl); 1997 May; 131(1):71-8. PubMed ID: 9181638
[TBL] [Abstract][Full Text] [Related]
5. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.
Gatley SJ; Ding YS; Volkow ND; Chen R; Sugano Y; Fowler JS
Eur J Pharmacol; 1995 Aug; 281(2):141-9. PubMed ID: 7589201
[TBL] [Abstract][Full Text] [Related]
6. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration.
Ding YS; Gatley SJ; Thanos PK; Shea C; Garza V; Xu Y; Carter P; King P; Warner D; Taintor NB; Park DJ; Pyatt B; Fowler JS; Volkow ND
Synapse; 2004 Sep; 53(3):168-75. PubMed ID: 15236349
[TBL] [Abstract][Full Text] [Related]
7. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
[TBL] [Abstract][Full Text] [Related]
8. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.
Volkow ND; Fowler JS; Logan J; Gatley SJ; Dewey SL; MacGregor RR; Schlyer DJ; Pappas N; King P; wang GJ
J Nucl Med; 1995 Jul; 36(7):1289-97. PubMed ID: 7790958
[TBL] [Abstract][Full Text] [Related]
9. Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.
Fowler JS; Volkow ND; Logan J; Gatley SJ; Pappas N; King P; Ding YS; Wang GJ
Synapse; 1998 Feb; 28(2):111-6. PubMed ID: 9450511
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
Volkow ND; Gatley SJ; Fowler JS; Chen R; Logan J; Dewey SL; Ding YS; Pappas N; King P; MacGregor RR
Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
Gatley SJ; Volkow ND; Fowler JS; Dewey SL; Logan J
Synapse; 1995 Jun; 20(2):137-44. PubMed ID: 7570343
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporters decrease with age.
Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Hitzemann R; Smith G; Fields SD; Gur R
J Nucl Med; 1996 Apr; 37(4):554-9. PubMed ID: 8691238
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Hume SP; Luthra SK; Brown DJ; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll FI; Kuhar MJ; Brooks DJ
Nucl Med Biol; 1996 Apr; 23(3):377-84. PubMed ID: 8782251
[TBL] [Abstract][Full Text] [Related]
15. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
Helfenbein J; Sandell J; Halldin C; Chalon S; Emond P; Okubo Y; Chou YH; Frangin Y; Douziech L; Gareau L; Swahn CG; Besnard JC; Farde L; Guilloteau D
Nucl Med Biol; 1999 Jul; 26(5):491-9. PubMed ID: 10473187
[TBL] [Abstract][Full Text] [Related]
16. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.
Halldin C; Farde L; Lundkvist C; Ginovart N; Nakashima Y; Karlsson P; Swahn CG
Synapse; 1996 Apr; 22(4):386-90. PubMed ID: 8867033
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
[TBL] [Abstract][Full Text] [Related]
18. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.
Lundkvist C; Halldin C; Swahn CG; Hall H; Karlsson P; Nakashima Y; Wang S; Milius RA; Neumeyer JL; Farde L
Nucl Med Biol; 1995 Oct; 22(7):905-13. PubMed ID: 8547888
[TBL] [Abstract][Full Text] [Related]
19. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
Laruelle M; Baldwin RM; Malison RT; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Sybirska EH; Zimmermann RC; Wisniewski G; Neumeyer JL
Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
